Chronic Lymphocytic Leukemia Stem Cell Treatments
Innovative Regenerative Approach for Blood Disorders
Chronic Lymphocytic Leukemia (CLL) is a type of cancer that affects the blood and bone marrow, causing an abnormal increase of white blood cells known as lymphocytes. At 1 STEM CELL, we provide advanced stem cell–based therapies designed to support immune modulation and hematopoietic recovery in patients affected by this condition.
Our approach focuses on using mesenchymal stem cells (MSCs), known for their anti-inflammatory and immunomodulatory properties, to assist the patient’s system in regulating abnormal cell growth. While not a direct cure, this adjunctive regenerative therapy may help improve quality of life, reduce complications from conventional treatments, and enhance immune balance.
By promoting tissue repair and supporting bone marrow function, stem cell therapy complements ongoing medical management and can contribute to better overall well-being in selected cases.
Questions and Answers About CLL Stem Cell Therapy
Q: What is the role of stem cells in treating CLL?
Stem cells may help regulate immune activity, reduce inflammation, and promote hematopoietic support for patients undergoing or recovering from traditional cancer therapies.
Q: Is this therapy a replacement for chemotherapy?
No. Stem cell therapy is considered a supportive or complementary treatment designed to improve patient recovery, minimize side effects, and strengthen immune response alongside conventional care.
Q: What type of stem cells are used?
At 1 STEM CELL, we use umbilical cord–derived mesenchymal stem cells (MSCs) that meet high safety and quality standards for regenerative medicine applications.
Q: Who can benefit from this therapy?
Patients with CLL or other hematologic disorders seeking complementary regenerative options under medical supervision may benefit from personalized treatment plans.
Q: Are the treatments safe?
All stem cell procedures at our clinic are conducted following FDA-compliant protocols, ensuring sterile environments and ethical sourcing.